A Virtual Event on Lobular Breast Cancer: Wednesday, October 15

Join us for a virtual event on Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease with Sasha Stanton, M.D., Ph.D., Providence Cancer Institute, on Wednesday, October 15 at 6:00-7:30 pm.

Dr. Stanton will discuss the current understanding of lobular breast cancer, highlighting what is known and what is missing. As well as explore data on the spatial immune environment of invasive lobular carcinoma (ILC) and lobular carcinoma in situ (LCIS). She will discuss breast cancer recurrence, focusing on general breast cancer cases and lobular cancer, and discuss its implications for patient outcomes. Dr. Stanton will also present data on the development of a lobular prevention vaccine.

Sasha Stanton has an M.D., Ph.D. from the Albert Einstein College of Medicine in New York. She completed her residency in Internal Medicine at New York Hospital/Weil Cornell Medical Center and her Hematology Oncology Fellowship at the University of Washington/Fred Hutchinson Cancer Research Center. She also completed an immunology postdoctoral fellowship with her mentor Dr. Mary L Disis at the University of Washington Cancer Vaccine Institute and was promoted to assistant professor in 2017.

Dr. Stanton is an assistant member in the Department of medical oncology at the Earle A. Chiles Research Institute. Her research focuses on antigen discovery and vaccine design for breast and head and neck squamous cell cancer prevention vaccines. She is also interested in immune modification of the tumor immune environment of breast cancer. Her clinical work is with the Breast Oncology group at the Providence Cancer Institute – Portland.

Zoom link: https://us02web.zoom.us/j/83321148394